ArticleJournal of clinical hypertension (Greenwich, Conn.)2018

Nocturnal hypertension in diabetes: Potential target of sodium/glucose cotransporter 2 (SGLT2) inhibition.

Kazuomi Kario et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.